• search hit 108 of 7967
Back to Result List

Oncogenic BRAF alterations and their role in brain tumors

  • Alterations of the v-raf murine sarcoma viral oncogene homolog B (BRAF) have been extensively studied in several tumor entities and are known to drive cell growth in several tumor entities. Effective targeted therapies with mutation-specific small molecule inhibitors have been developed and established for metastasized malignant melanoma. The BRAF V600E mutation and KIAA1549-BRAF fusion are alterations found in several brain tumors and show a distinct prognostic impact in some entities. Besides the diagnostic significance for the classification of central nervous system tumors, these alterations present possible therapy targets that may be exploitable for oncological treatments, as it has been established for malignant melanomas. In this review the different central nervous system tumors harboring BRAF alterations are presented and the diagnostic significance, prognostic role, and therapeutic potential are discussed.

Download full text files

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Felix BehlingORCiDGND, Jens Schittenhelm
URN:urn:nbn:de:bvb:384-opus4-1251645
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/125164
ISSN:2072-6694OPAC
Parent Title (English):Cancers
Publisher:MDPI
Type:Article
Language:English
Year of first Publication:2019
Publishing Institution:Universität Augsburg
Release Date:2025/09/30
Volume:11
Issue:6
First Page:794
DOI:https://doi.org/10.3390/cancers11060794
Institutes:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum
Medizinische Fakultät / Professur für translationale onkologische Neurochirurgie
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Licence (German):CC-BY 4.0: Creative Commons: Namensnennung (mit Print on Demand)